Hong Liu

Dr. Liu is a seasoned R&D leader with extensive industrial and academic experience in oncology drug development and clinical experience in treating patients and conducting clinical research studies. Before joining Anticancer Bioscience, he served for more than a decade as VP of R&D at Eureka Therapeutics. He also served as a postdoc in the laboratory of J. Michael Bishop at the University of California, San Francisco, having started his career as a physician at the 1st Affiliated Hospital of Xi’an Jiaotong University, China. He has a Ph.D. from the University of California, Berkeley, USA.